Grant: Engage Grants Program
University of Manitoba
$25,000.00
Deep learning for prioritizing small molecules candidates for drug repositioning
FY 2019-20
Summary
Sightline Innovation is a company that provides artificial intelligence products and solutions for businesses around the world. One of the areas that the company is interested in uses its deep learning cloud services to develop custom applications of the existing drugs for new therapeutic purposes, also called drug repositioning, in cancer that can be easily adjusted to specific client's requirements. Currently, the company has access to a large amount of pharmacogenomic data and drug compound structures for various drug repositioning tasks from different clients. The company is interested in exploiting these data to develop deep learning based solutions for drug repositioning systems that can be quickly adapted to specific clients. In the proposed research, we will accomplish this goal by unifying the structures of small molecules and pharmacogenomic data with neural networks of various architectures . Dr. Hu is a leader in developing deep learning models for drug repositioning. The Hu lab has more than 10 graduate student trainees and research associates with background in computer science, statistics, medical genetics, medicine and others. Sightline Innovation provides cutting-edge artificial intelligence solutions to multiple industries, including pharmaceutical industry. The company is constantly exploring new ways to enhance their products with advanced intelligence and analytic capabilities. The technology solutions developed in this project will provide the partner company with some unique product and market advantage, which may improve the lives of Canadians..
Program
Engage Grants Program
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
543968-2019
Name nom
Hu, Pingzhao
Department département
Biochemistry and Medical Genetics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Deep learning for prioritizing small molecules candidates for drug repositioning
Keyword
NSERC
Application summary
Sightline Innovation is a company that provides artificial intelligence products and solutions for businesses around the world. One of the areas that the company is interested in uses its deep learning cloud services to develop custom applications of the existing drugs for new therapeutic purposes, also called drug repositioning, in cancer that can be easily adjusted to specific client's requirements. Currently, the company has access to a large amount of pharmacogenomic data and drug compound structures for various drug repositioning tasks from different clients. The company is interested in exploiting these data to develop deep learning based solutions for drug repositioning systems that can be quickly adapted to specific clients. In the proposed research, we will accomplish this goal by unifying the structures of small molecules and pharmacogenomic data with neural networks of various architectures . Dr. Hu is a leader in developing deep learning models for drug repositioning. The Hu lab has more than 10 graduate student trainees and research associates with background in computer science, statistics, medical genetics, medicine and others. Sightline Innovation provides cutting-edge artificial intelligence solutions to multiple industries, including pharmaceutical industry. The company is constantly exploring new ways to enhance their products with advanced intelligence and analytic capabilities. The technology solutions developed in this project will provide the partner company with some unique product and market advantage, which may improve the lives of Canadians..